Manufacturing Process Change for Crizotinabex. Manufacturing Process Change for Crizotinabex — major revision. Impacts 4 markets and 3 variations.

Change Number
CHG-2021-0268
Type
Manufacturing Process Change
Status
Pending
Owner
Marcus Webb
Initiated
2023-06-17
Description

Manufacturing Process Change for Crizotinabex — major revision

Impacted Markets (4)
AU — AustraliaGB — United KingdomSG — SingaporeIN — India
Impacted Modules
3.2.P.33.2.P
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved